Ken Griffin Tff Pharmaceuticals, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $10,234 - $18,326	-23,800 Reduced 51.52%	22,400 $10,000
Q1 2023 May 15, 2023	SELL	$0.62 - $1.1 $7,874 - $13,970	-12,700 Reduced 21.56%	46,200 $31,000
Q4 2022 Feb 14, 2023	BUY	$0.84 - $100.75 $22,932 - $2.75 Million	27,300 Added 86.39%	58,900 $61,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $94,044 - $2.37 Million	-20,400 Reduced 39.23%	31,600 $128,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.